Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Invested Capital (2021 - 2025)

Firefly Neuroscience has reported Return on Invested Capital over the past 7 years, most recently at 1.02% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 1.02% for Q4 2025, down 921.0% from a year ago — trailing twelve months through Dec 2025 was 1.02% (down 921.0% YoY), and the annual figure for FY2025 was 2.23%, up 4475.0%.
  • Return on Invested Capital for Q4 2025 was 1.02% at Firefly Neuroscience, down from 0.88% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AIFF hit a ceiling of 10.4% in Q2 2024 and a floor of 6.42% in Q1 2023.
  • Median Return on Invested Capital over the past 5 years was 0.32% (2022), compared with a mean of 0.46%.
  • Biggest five-year swings in Return on Invested Capital: skyrocketed 1240bps in 2024 and later tumbled -1168bps in 2025.
  • Firefly Neuroscience's Return on Invested Capital stood at 0.0% in 2021, then crashed by -36096bps to 1.15% in 2022, then soared by 231bps to 1.51% in 2023, then surged by 443bps to 8.19% in 2024, then plummeted by -113bps to 1.02% in 2025.
  • The last three reported values for Return on Invested Capital were 1.02% (Q4 2025), 0.88% (Q3 2025), and 1.28% (Q2 2025) per Business Quant data.